Skip to main content
. 2012 Feb 13;7(2):e31279. doi: 10.1371/journal.pone.0031279

Figure 5. Cardiac ILK gene therapy increases left ventricular cardiomyocyte proliferation in doxorubicin-induced heart failure.

Figure 5

A–B, Phosphohistone-H3 staining for mitotic analysis (brown, arrows), in adeno-ILK (A) and adeno-null (B) treated rats. C-D, Ki-67 staining showing more positive cells (brown, arrows) in adeno-ILK tissue sections (C) than in adeno-null sections (D). E–F, Accumulated results showing phosphohistone-H3 (E) or Ki-67 (F) positive cardiomyocytes in adeno-ILK and adeno-null groups. n = 6 per group. *P<0.05 versus adeno-null group. Scale bars: 100 µm.